Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

The Respirgard II 303 breathing circuit filter is NOT an "absolute filter".

Demers RR, Burciaga C, Sousa M.

Respir Care. 2016 Dec;61(12):1710-1711. No abstract available.

2.

A highly sensitive and selective LC-MS/MS method to quantify asunaprevir, an HCV NS3 protease inhibitor, in human plasma in support of pharmacokinetic studies.

Kandoussi H, Jiang H, Zeng J, Zheng N, Kadiyala P, Eley T, He B, Garimella T, Demers R, Cojocaru L, Aubry AF, Arnold ME.

J Pharm Biomed Anal. 2016 Feb 5;119:145-51. doi: 10.1016/j.jpba.2015.11.028. Epub 2015 Nov 23.

PMID:
26683987
3.

Multiplexed LC-MS/MS method for the simultaneous quantitation of three novel hepatitis C antivirals, daclatasvir, asunaprevir, and beclabuvir in human plasma.

Jiang H, Kandoussi H, Zeng J, Wang J, Demers R, Eley T, He B, Burrell R, Easter J, Kadiyala P, Pursley J, Cojocaru L, Baker C, Ryan J, Aubry AF, Arnold ME.

J Pharm Biomed Anal. 2015 Mar 25;107:409-18. doi: 10.1016/j.jpba.2015.01.027. Epub 2015 Jan 20.

PMID:
25676854
4.

Sensitive and accurate liquid chromatography-tandem mass spectrometry methods for quantitative determination of a novel hepatitis C NS5B inhibitor BMS-791325 and its active metabolite in human plasma and urine.

Jiang H, Demers R, Kandoussi H, Burrell R, Eley T, Kadiyala P, Cojocaru L, Baker C, Ryan J, Aubry AF, Arnold ME, Zeng J.

J Pharm Biomed Anal. 2015 Mar 25;107:17-23. doi: 10.1016/j.jpba.2014.12.011. Epub 2014 Dec 17.

PMID:
25562845
5.

Quantitative determination of free/bound atazanavir via high-throughput equilibrium dialysis and LC-MS/MS, and the application in ex vivo samples.

Xu XS, Rose A, Demers R, Eley T, Ryan J, Stouffer B, Cojocaru L, Arnold M.

Bioanalysis. 2014;6(23):3169-82. doi: 10.4155/bio.14.251.

PMID:
25529885
6.

Interactions and structural variability of β-carboxysomal shell protein CcmL.

Keeling TJ, Samborska B, Demers RW, Kimber MS.

Photosynth Res. 2014 Sep;121(2-3):125-33. doi: 10.1007/s11120-014-9973-z. Epub 2014 Feb 7.

PMID:
24504539
7.

Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study.

Darwish-Yassine M, Berenji M, Wing D, Copeland G, Demers RY, Garlinghouse C, Fagerlin A, Newth GE, Northouse L, Holmes-Rovner M, Rovner D, Sims J, Wei JT.

J Cancer Surviv. 2014 Mar;8(1):121-30. doi: 10.1007/s11764-013-0312-8. Epub 2013 Nov 10.

PMID:
24214413
8.

Subdomain location of mutations in cardiac actin correlate with type of functional change.

Mundia MM, Demers RW, Chow ML, Perieteanu AA, Dawson JF.

PLoS One. 2012;7(5):e36821. doi: 10.1371/journal.pone.0036821. Epub 2012 May 8.

9.

Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: method validation and overcoming specific and non-specific binding at low concentrations.

Xu XS, Demers R, Gu H, Christopher LJ, Su H, Cojocaru L, Boulton DW, Kirby M, Stouffer B, Humphreys WG, Arnold ME.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Mar 15;889-890:77-86. doi: 10.1016/j.jchromb.2012.01.033. Epub 2012 Feb 6.

PMID:
22349123
10.

Dalbavancin: Quantification in human plasma and urine by a new improved high performance liquid chromatography-tandem mass spectrometry method.

Alebic-Kolbah T, Demers R, Cojocaru L.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Sep 1;879(25):2632-41. doi: 10.1016/j.jchromb.2011.07.027. Epub 2011 Jul 26.

PMID:
21831727
11.

Primary care perspectives on prostate cancer survivorship: implications for improving quality of care.

Skolarus TA, Holmes-Rovner M, Northouse LL, Fagerlin A, Garlinghouse C, Demers RY, Rovner DR, Darwish-Yassine M, Wei JT.

Urol Oncol. 2013 Aug;31(6):727-32. doi: 10.1016/j.urolonc.2011.06.002. Epub 2011 Jul 20.

12.

Primary care perspectives on prostate cancer screening.

Skolarus TA, Holmes-Rovner M, Northouse LL, Fagerlin A, Garlinghouse C, Demers RY, Rovner DR, Darwish-Yassine M, Wei JT.

Nurse Pract. 2011 Jun;36(6):39-44. doi: 10.1097/01.NPR.0000397913.82821.bc.

PMID:
21572298
13.

Arginylation regulates intracellular actin polymer level by modulating actin properties and binding of capping and severing proteins.

Saha S, Mundia MM, Zhang F, Demers RW, Korobova F, Svitkina T, Perieteanu AA, Dawson JF, Kashina A.

Mol Biol Cell. 2010 Apr 15;21(8):1350-61. doi: 10.1091/mbc.E09-09-0829. Epub 2010 Feb 24.

14.

Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer.

Tewari AK, Gold HT, Demers RY, Johnson CC, Yadav R, Wagner EH, Yood MU, Field TS, Divine G, Menon M.

Urology. 2009 Mar;73(3):624-30. doi: 10.1016/j.urology.2008.09.081. Epub 2009 Jan 23. Erratum in: Urology. 2009 Jul;74(1):239. Yood, Marianne Ulcickas [added].

15.

Factors contributing to the racial differences in prostate cancer mortality.

Tewari A, Horninger W, Pelzer AE, Demers R, Crawford ED, Gamito EJ, Divine G, Johnson CC, Bartsch G, Menon M.

BJU Int. 2005 Dec;96(9):1247-52.

16.

Detection of trichothecene mycotoxins in sera from individuals exposed to Stachybotrys chartarum in indoor environments.

Brasel TL, Campbell AW, Demers RE, Ferguson BS, Fink J, Vojdani A, Wilson SC, Straus DC.

Arch Environ Health. 2004 Jun;59(6):317-23.

PMID:
16238166
17.

Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan.

Patel DA, Bock CH, Schwartz K, Wenzlaff AS, Demers RY, Severson RK.

Cancer Causes Control. 2005 Apr;16(3):263-73.

18.

Effects of false-positive prostate cancer screening results on subsequent prostate cancer screening behavior.

Ford ME, Havstad SL, Demers R, Cole Johnson C.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):190-4.

19.

Determination of derivatized l-alanosine in plasma by liquid chromatography-tandem mass spectrometry.

Gantverg A, Elliott G, Pineault J, Demers R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Apr 25;803(2):311-5.

PMID:
15063341
20.
21.

Recombinant human erythropoietin usage in a large academic medical center.

Bilenker JH, Demers R, Porter DL, Wasserstein AG, Peters E, Manaker S.

Am J Manag Care. 2002 Aug;8(8):742-7.

22.

Is the gastrointestinal tract the sole source of organisms in ventilator-associated pneumonia?

Demers RR.

Respir Care. 2002 Jun;47(6):696; author reply 696-9. No abstract available.

PMID:
12078653
23.

Relevant patient and tumor considerations for early prostate cancer treatment.

Leak B, Wei JT, Gabel M, Peabody JO, Menon M, Demers R, Tewari A.

Semin Urol Oncol. 2002 Feb;20(1):39-44. Review.

PMID:
11828356
24.

Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional study.

Tewari A, Issa M, El-Galley R, Stricker H, Peabody J, Pow-Sang J, Shukla A, Wajsman Z, Rubin M, Wei J, Montie J, Demers R, Johnson CC, Lamerato L, Divine GW, Crawford ED, Gamito EJ, Farah R, Narayan P, Carlson G, Menon M.

Mol Urol. 2001 Winter;5(4):163-9.

25.

Predictive modeling techniques in prostate cancer.

Tewari A, Porter C, Peabody J, Crawford ED, Demers R, Johnson CC, Wei JT, Divine GW, O'Donnell C, Gamito EJ, Menon M.

Mol Urol. 2001 Winter;5(4):147-52. Review.

26.

Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality.

Demers RY, Tiwari A, Wei J, Weiss LK, Severson RK, Montie J.

Cancer. 2001 Nov 1;92(9):2309-17.

PMID:
11745285
27.

Managing up in times of financial crisis.

Demers RF.

Am J Health Syst Pharm. 2001 Oct 1;58 Suppl 1:S7-10.

PMID:
11592354
28.

Bacterial/viral filtration: let the breather beware!

Demers RR.

Chest. 2001 Oct;120(4):1377-89.

PMID:
11591584
29.
30.

Impact of breast carcinoma on African-American women: the Detroit experience.

Newman LA, Carolin K, Simon M, Kosir M, Hyrniuk W, Demers R, Grossbart Schwartz A, Visscher D, Peters W, Bouwman D.

Cancer. 2001 May 1;91(9):1834-43.

PMID:
11335911
31.

Consistency of occupational exposure history from pattern and model makers.

Neale AV, Demers RY, Severson RK.

J Occup Environ Med. 2000 Jan;42(1):76-82.

PMID:
10652692
32.

The Henry Ford Health System.

Demers RY, Chapman RA, Flasch MH, Martin C, McCarthy BD, Nelson S.

Cancer. 1998 May 15;82(10 Suppl):2043-6.

PMID:
9587105
33.

Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results database.

Ramalingam S, Pawlish K, Gadgeel S, Demers R, Kalemkerian GP.

J Clin Oncol. 1998 Feb;16(2):651-7.

PMID:
9469354
34.
35.

Family medicine in Japan.

Smith BW, Demers R, Garcia-Shelton L.

Arch Fam Med. 1997 Jan-Feb;6(1):59-62. Review.

PMID:
9003172
36.

Neurobehavioral and health-related deficits in solvent-exposed painters.

Grosch JW, Neale AV, Demers RY.

Am J Ind Med. 1996 Nov;30(5):623-32.

PMID:
8909612
37.

The ribavirin debate.

Demers RR.

Pediatrics. 1996 Nov;98(5):1003-4. No abstract available.

PMID:
8909508
38.

Environmental medicine content in medical school curricula.

Schenk M, Popp SM, Neale AV, Demers RY.

Acad Med. 1996 May;71(5):499-501.

PMID:
9114870
39.

Medication use review process and information systems utilized for oncology chemotherapy quality improvement.

Bourret JA, Demers RF, Wordell D, Irani M, Baker J, Evangelista C.

Pharm Pract Manag Q. 1996 Apr;16(1):1-17.

PMID:
10157736
40.

Increasing incidence of adenocarcinomas and carcinoid tumors of the small intestine in adults.

Severson RK, Schenk M, Gurney JG, Weiss LK, Demers RY.

Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):81-4.

41.

Prostate-specific antigen in a community screening program.

Schwartz KL, Kau TY, Severson RK, Demers RY.

J Fam Pract. 1995 Aug;41(2):163-8.

PMID:
7543556
42.

Recent trends in incidence and treatment of prostate cancer among elderly men.

Severson RK, Montie JE, Porter AT, Demers RY.

J Natl Cancer Inst. 1995 Apr 5;87(7):532-4. No abstract available.

PMID:
7707440
43.

Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987.

Pienta KJ, Demers R, Hoff M, Kau TY, Montie JE, Severson RK.

Urology. 1995 Jan;45(1):93-101; discussion 101-2.

PMID:
7817485
44.

Construction occupations, asbestos exposure, and cancer of the colon and rectum.

Demers RY, Burns PB, Swanson GM.

J Occup Med. 1994 Sep;36(9):1027-31.

PMID:
7823215
45.

Colorectal cancer incidence in pattern and model makers: evidence from a screening program.

Demers RY, Parsons KC.

Am J Ind Med. 1994 Jul;26(1):33-45.

PMID:
8074123
46.

Increasing incidence of cancer of the prostate. The experience of black and white men in the Detroit metropolitan area.

Demers RY, Swanson GM, Weiss LK, Kau TY.

Arch Intern Med. 1994 Jun 13;154(11):1211-6.

PMID:
8203988
47.

Significance of the inability to reproduce pulmonary function test results.

Neale AV, Demers RY.

J Occup Med. 1994 Jun;36(6):660-6.

PMID:
8071730
48.

Prostate cancer trends in southeast Michigan 1973-1992.

Demers RY.

In Vivo. 1994 May-Jun;8(3):429-31.

PMID:
7528558
49.

Lymphocytopenia and occupational exposures among pattern and model makers.

Demers PA, Schade WJ, Demers RY.

Scand J Work Environ Health. 1994 Apr;20(2):107-12.

50.

Family practice in Cuba: evolution into the 1990s.

Demers RY, Kemble S, Orris M, Orris P.

Fam Pract. 1993 Jun;10(2):164-8.

PMID:
8359605

Supplemental Content

Loading ...
Support Center